Translating Documentation and Communication in Clinical Research - Virtual Conference

• Understanding the value of localization in clinical trials and how it drives the need for quality medical translation
• The difference between translation and localization in ensuring not only linguistic transfer but also content, cultural, and technical issues

• Making the most of MT to streamline translation and reduce costs​
• Using AI to pre-empt quality issues before translation even begins​
• The benefits, savings and efficiencies of MT in practice

• Maximizing trial participant understanding
• Ensuring diversity in trials
• Improving patient engagement through effective communication

• Language services play a huge role in overcoming three major challenges facing clinical trial patient recruitment and retention,
• The presentation will look at the role of translation in increasing enrolment, widening patient diversity, and reaching patients online.
• It will focus on the importance of people, process, and technology in ensuring language helps optimise patient recruitment and retention

• Listening and analysis of the contest
• We build/adapt the right solution for the right study
• To answer to the need of our stakeholders (patients, investigators, ..)

 Global clinical trial success hinges on culturally appropriate patient engagement. We will be covering best practices to recruit and retain study patients in global clinical trials

The discussion will explore how having a good medical writer involved in writing protocols brings value in many dimensions, including:

• Efficiencies during protocol development by keeping authors focused on content and key objectives relative to registration goals
• Improved data quality and study efficiency through consistency and clear messaging to study teams
• Streamlining downstream documents (CSR, CTD summaries) by ensuring the protocol provides the right information for ease of reuse

• How to partner for maximum value – have a clear strategy
• Observing the correct medical terminology and ensuring the language is clear and translated correctly
• Linguistic validation – back translation, reconciliation, cognitive debriefing

Each phase of a clinical trial involves an intricate dance among collaborating parties. A successful trial hinges upon the ability of multiple vendors to support the trial sponsor in a series of interlocking steps that can feel as complex and multi-faceted as the disease the sponsor is striving to treat.

At any time, various vendors—from language service providers (LSPs) to CROs to eCOA providers— must work together to drive efficiency and ensure the quality and accuracy of trial data. Now more than ever, as companies seek to do more with less, collaboration is key.

In this session we’ll hear how Clinical Ink and RWS partnered to streamline an unwieldy eCOA process, including:

• Implement tools to automate review/approvals
• Improve quality by allowing language experts to review translation updates in real-time, without the need to involve manual effort from Clinical Ink.
• Reduce the total number of touchpoints between Clinical Ink and RWS, which can save time and potentially lower costs for the sponsor client.

• Supporting diverse representation with decentralized trials and the role of translation
• Considering cultural values and behaviours – Overcoming barriers in communication

• Patient Questionnaires should be localized with the utmost care to medical accuracy
• Experience-based assurance of patient’s understanding of medical terminology
• Insights from Cognitive Debriefing projects
• Balancing between accurate terminology requirements and patient-centric clinical trial phrasing

Join our expert panel lineup, where we assess the translation thoughts for patients in clinical trials and identify any localize considerations when setting up your trial